Henry Schein (HSIC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

The purchase is expected to complement Thermo’s clinical research services, as companies are conducting more clinical trials.

Executives under activist pressure turn to private capital groups once seen as ‘barbarians’ that challenged big companies ...

Maybe the Nerds craze has somewhat abated since last year, but they're still one of the most in-demand Halloween candies. And ...

Wall Street expects a year-over-year increase in earnings on higher revenues when McKesson (MCK) reports results for the ...

The following were recorded at the Lancaster County Recorder of Deeds Office for Oct. 13-17: AKRON BOROUGH Hackman Mark E, ...

Wall Street trading got off to a mixed start on Thursday after Federal Reserve chairman Jerome Powell hinted that the central ...

A PBS documentary profiles the storied diplomat who was obsessed, for better and worse, with keeping his adopted country safe ...

The Dental Implants Market is undergoing a period of dynamic transformation. Advances in dental science, material engineering ...

The companies have teamed to develop an alternative to TAVR that combines the benefits of a less-invasive procedure with the ...